News about Clean Rooms

NPPA extends ceiling price regulation on orthopaedic knee implants for one more year

NPPA extends ceiling price regulation on orthopaedic knee implants for one more year

The National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price it imposed on orthopaedic knee implants for knee replacement system in August, 2017, to one more year up to September 15, 2022. The ceiling price was applicable till September 15, 2021, according to an earlier notification

Clean Rooms | 20/09/2021 | By Darshana

DCGI classifies 247 medical devices including PPEs, OT equipment and others

DCGI classifies 247 medical devices including PPEs, OT equipment and others

The Drug Controller General (India) has classified medical devices including personal protective equipment, devices in general hospitals and those pertaining to nephrology and renal care, pain management, operation theatre and certain softwares

Clean Rooms | 20/09/2021 | By Darshana

ABB drives enhance safety & energy efficiency at Bharat Biotech?s Covaxin production unit with cleanroom infrastructure

ABB drives enhance safety & energy efficiency at Bharat Biotech?s Covaxin production unit with cleanroom infrastructure

ABB drives play a key role in the cleanroom infrastructure of Bharat Biotech, India?s first indigenous Covid-19 vaccine manufacturer. The inbuilt application functions of ABB?s ACS560 drives help in maintaining the right environmental condition

Clean Rooms | 08/09/2021 | By Darshana

US FDA updates its March 2020 norms to conduct human studies

US FDA updates its March 2020 norms to conduct human studies

The global regulator which noted the Covid-19 as a public health emergency now insists that the clinical trial industry, investigators, and institutional Review Boards need to maintain compliance with good clinical practice (GCP), minimize risks to trial during the ongoing pandemic

Clean Rooms | 06/09/2021 | By Darshana

Recipharm launches new laboratory to expand analytical services offering

Recipharm launches new laboratory to expand analytical services offering

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru. The new lab has been in full operation since August 1, 2021

Clean Rooms | 26/08/2021 | By Darshana

Covid 19 treatment: Vir Biotechnology receives AustralianTGA marketing approval for sotrovimab

Covid 19 treatment: Vir Biotechnology receives AustralianTGA marketing approval for sotrovimab

Vir Biotechnology announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline (GSK). This announcement follows news shared by GSK Australia that the Australian Therapeutic Goods Administration (TGA) has granted provisional marketing authorization

Clean Rooms | 25/08/2021 | By Darshana

Astellas Venture Management, LabCentral partner to help emerging biotechs accelerate preclinical scientific research

Astellas Venture Management, LabCentral partner to help emerging biotechs accelerate preclinical scientific research

Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-sciences startups, announced their collaboration on the "Future Innovator Prize" formerly known as the Astellas Golden Ticket Competition

Clean Rooms | 20/08/2021 | By Darshana

Already approved drugs may be considered as new drug, if certain changes occur in active substance: DCGI

Already approved drugs may be considered as new drug, if certain changes occur in active substance: DCGI

The Drugs Controller General (India) has said that certain changes in the active substance of an approved drug may lead to change in drug specification and require validation of the manufacturing process

Clean Rooms | 27/07/2021 | By Darshana

US FDA grants breakthrough therapy status to Roche's Venclexta

US FDA grants breakthrough therapy status to Roche's Venclexta

Roche announced that Venclexta (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the revised International Prognostic

Clean Rooms | 22/07/2021 | By Darshana

Ipsen and IRLAB ink pact to develop & commercialise newl dopamine D3-receptor antagonist, mesdopetam to treat Parkinson?s disease

Ipsen and IRLAB ink pact to develop & commercialise newl dopamine D3-receptor antagonist, mesdopetam to treat Parkinson?s disease

Ipsen and IRLAB announced the signing of a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is being assessed in phase IIb clinical trials as a potential treatment option

Clean Rooms | 17/07/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology